Arraignment and Pretrial Provisions

ORS 135.893
Diversion conditions related to medical use of cannabis


(1)

As used in this section, “cannabinoid concentrate,” “cannabinoid extract,” “medical cannabinoid product,” “registry identification card” and “usable marijuana” have the meanings given those terms in ORS 475B.791 (Definitions for ORS 475B.785 to 475B.949).

(2)

For a person who holds a registry identification card who is subject to a diversion agreement under ORS 135.891 (Conditions of diversion agreement), the diversion conditions related to the use of usable marijuana, medical cannabinoid products, cannabinoid concentrates or cannabinoid extracts must be imposed in the same manner as the diversion conditions related to prescription drugs. [2016 c.24 §53d; 2019 c.292 §7]
§§ 135.881 to 135.901

Notes of Decisions

When district attorney terminates diversion and the existence of findings on the termination is disputed, the court must provide a procedure for determining whether the requisite facts exist. State ex rel Harmon v. Blanding, 292 Or 752, 644 P2d 1082 (1982)


Source

Last accessed
Jun. 26, 2021